Digestives & Intestinal Remedies - Jordan

  • Jordan
  • In the year 2024, the Digestives & Intestinal Remedies market market in Jordan is projected to generate a revenue of US$13.88m.
  • This market is expected to grow at an annual rate of 5.17% from 2024 to 2029, according to the Compound Annual Growth Rate (CAGR).
  • When compared globally, in China leads the way in terms of revenue generation, with a staggering US$4,408.00m in 2024.
  • In relation to the total population figures, each person in Jordan is estimated to contribute US$1.22 to the revenue of the Digestives & Intestinal Remedies market market in 2024.
  • In Jordan, there is a growing demand for natural digestive remedies as consumers become more health-conscious.

Key regions: Brazil, India, United Kingdom, Germany, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in Jordan is experiencing steady growth due to changing customer preferences, emerging trends, and local special circumstances. Customer preferences in the Digestives & Intestinal Remedies market in Jordan are shifting towards natural and herbal remedies. Jordanians are increasingly seeking products that are derived from natural ingredients and have minimal side effects. This preference is driven by a growing awareness of the potential harmful effects of synthetic drugs and a desire for more holistic healthcare solutions. As a result, there has been a rise in the demand for digestive supplements and remedies that are based on traditional herbal medicine.Trends in the Digestives & Intestinal Remedies market in Jordan include the increasing popularity of probiotics and digestive enzymes. Probiotics are live bacteria and yeasts that are beneficial to digestive health, while digestive enzymes help break down food and improve nutrient absorption. These products are gaining traction in the market as consumers become more aware of the importance of maintaining a healthy gut microbiome. Additionally, there is a growing trend of incorporating digestive health into overall wellness routines, with consumers seeking products that promote both digestive and immune health.Local special circumstances in Jordan contribute to the development of the Digestives & Intestinal Remedies market. Jordan has a high prevalence of digestive disorders, such as irritable bowel syndrome and gastroesophageal reflux disease. This has created a significant demand for products that alleviate symptoms and improve overall digestive health. Furthermore, the country has a large population of expatriates and tourists, who often experience digestive issues due to dietary changes and unfamiliar environments. This presents an opportunity for the market to cater to the needs of these temporary residents.Underlying macroeconomic factors also play a role in the growth of the Digestives & Intestinal Remedies market in Jordan. The country has a stable economy and a relatively high standard of living compared to other countries in the region. This allows consumers to allocate a portion of their income towards healthcare and wellness products, including digestive remedies. Furthermore, the government of Jordan has been actively promoting the development of the healthcare sector, which includes initiatives to improve access to quality healthcare services and products.In conclusion, the Digestives & Intestinal Remedies market in Jordan is witnessing growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The shift towards natural and herbal remedies, the popularity of probiotics and digestive enzymes, the high prevalence of digestive disorders, and the stable economy contribute to the development of the market. This presents opportunities for companies operating in the Digestives & Intestinal Remedies sector to cater to the evolving needs of Jordanian consumers.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)